Mode
Text Size
Log in / Sign up
Phase 4 Completed N=110 Randomized Single-blind Treatment

Efficacy of Oral vs. Intravenous Acetaminophen

Source: ClinicalTrials.gov NCT02643394 ↗
Enrolled (actual)
110
Serious AEs
0.0%
Results posted
May 2018
Primary outcomePrimary: Postoperative Pain Score on the Scale of 10 (0=No Pain and 10=Worst Pain) — 2; 2 units on a scale — p=0.252
◆ Published Evidence
No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

The comparative efficacy of intravenous (IV) to oral (PO-'per os') acetaminophen in the management of postoperative pain is understudied and largely unknown. In this observer blinded randomized clinical trial, investigators aim to determine the comparative efficacy of PO (preoperative) vs. IV (intraoperative) acetaminophen in a sinus surgery population.

Outcome Measures

OutcomeResultp-value
PRIMARY
Postoperative Pain Score on the Scale of 10 (0=No Pain and 10=Worst Pain)
2; 2 0.252
SECONDARY
Morphine Equivalents of Postoperative Opioid Usage
5; 5 0.402

Eligibility Criteria

Inclusion Criteria

  • Adult patients aged 18 years or older
  • Undergoing elective sinus surgery at Zale Lipshy Hospital

Exclusion Criteria

  • Inability of the patient to follow directions or comprehend either English or Spanish language.
  • Disorders of the liver which would make acetaminophen contraindicated (such as hepatitis, liver failure, prior liver transplant, etc).
  • Patients with chronic pain manifest by a baseline pain score > 4/10
  • Chronic opioid use (>2 weeks continuously), or illicit drug abuse
  • Body weight < 50 kg.
  • Patients with contraindications to any of the study drugs (such as Malignant Hyperthermia susceptible, celecoxib or sulfa allergy, etc.).
  • Patients who have taken analgesic medications on the morning of surgery (prior to arrival).
  • Allergy to acetaminophen
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02643394). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search